CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduate at Ciências Farmacêuticas from Universidade de Ribeirão Preto (1992), master's at Programa de Pós Graduação Em Biotecnologia from Universidade Estadual Paulista Júlio de Mesquita Filho (2000) and ph.d. at Programa de Pós Graduação Em Biotecnologia from Universidade Estadual Paulista Júlio de Mesquita Filho (2004). Has experience in Microbiology, focusing on Medical Microbiology, acting on the following subjects: controle microbiológico, odontologia, atividade antifúngica, rapd and atividade antibacteriana. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Histoplasma capsulatum var capsulatum is the dimorphic fungus that causes histoplasmosis, a lung infection that can spread to other organs, causing severe forms of the disease. Histoplasmosis is the fourth mycosis that most affects people annually and is distributed worldwide, being considered an Invasive Fungal Infection (IFI) and classified as of high global relevance by the WHO in 2022…
Histoplasma capsulatum variety capsulatum is a fungal pathogen which causes histoplasmosis that occurs as a result of inhalation of microconidea from mycelial phase, primarily affecting the lung which occurs the yeast differentiation, inducing a pulmonary infection and dissemination to other organs. Recently, a correlation between the H. capsulatum infection mode, and the formation of bio…
Histoplasma capsulatum var. capsulatum is a dimorphic fungus that causes histoplasmosis, a respiratory and systemic mycosis. The development of disease depends on the ability of Histoplasma yeast to survive and replicate within alveolar macrophages. In this context, it is known that adherence to host cells is the first step in the colonization and is essential for the establishment of inf…
Cryptococcus neoformans is a yeast of medical relevance, especially in immunocompromised patients, such as those affected by AIDS. This fungus can cause serious and sometimes drug-resistant systemic infections, being responsible for more than 180,000 deaths worldwide every year. Infection occurs predominantly through inhalation of fungal propagules, leading to a pulmonary infection that c…
Dimorphic fungi, including the genus Histoplasma, have a unique ability to undergo morphological changes, assuming a mycelial form in the soil and a yeast-like form in the host. This facultative intracellular pathogen is known for initiating respiratory infections in mammals that can progress to systemic infections. Additionally, its ability to form biofilms is a concern due to the inhere…
Cryptococcosis is a serious fungal infectious disease that is widespread and opportunistic, with significant public health implications, affecting both immunocompromised and immunocompetent individuals. The main causative agents are Cryptococcus neoformans and Cryptococcus gattii, which have ecological niches in pigeon droppings and decomposing tree matter, leading to their continuous dis…
Cryptococcus neoformans and Cryptococcus gattii are the encapsulated yeasts that cause cryptococcosis. Cryptococcosis is a systemic fungal disease clinically characterized by affecting immunocompromised (C.neoformans) and healthy (C.gattii) individuals, affecting the lower respiratory tract and subsequently the central nervous system (CNS). Antifungal treatment is aggressive, toxic, and c…
Histoplasmosis, an Invasive Fungal Infection (IFI), is caused by the dimorphic fungus Histoplasma capsulatum, which has a worldwide distribution. It is the fourth IFI with the highest number of annual cases, reaching more than 600 thousand people every year. In the last two decades, IFIs have increased worldwide and the number of patients at risk has grown dramatically. Recently, a correl…
(Only some records are available in English at this moment)
| 3 / 3 | Completed research grants |
| 2 / 2 | Ongoing scholarships in Brazil |
| 9 / 8 | Completed scholarships in Brazil |
| 14 / 13 | All research grants and scholarships |
| Associated processes | |